Next Generation Sequencing Core

下一代测序核心

基本信息

  • 批准号:
    10714179
  • 负责人:
  • 金额:
    $ 45.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2028-08-31
  • 项目状态:
    未结题

项目摘要

Summary Core C: Next Generation Sequencing core (NGSC) The next generation sequencing core (NGSC) will be responsible for all next generation sequencing activities by the four projects. All sequencing activities will be performed in Core C. RNA-Seq, ChIP-Seq, ATAC-Seq, Core C will be responsible for 1) performing NGS-assays; 2) generating library for Illumina next-generation sequencing, 3) mapping sequence data to EBV, KSHV, MPyV and human genomes, and 4) providing all follow-up bioinformatics and biostatistics analyses for the overall program. These goals will be accomplished in conjunction with the Penn Genomics, Next-Gen-Sequencing and Bioinformatics Cores, which provides Illumina Next Generation Sequencing as a core service. Final data management and analyses will be made accessible to each project investigator via a password protected shared web-based browser for program investigators. Expertise in all aspects of Next-Gen-Sequencing (NGS), Chromatin immunoprecipitation, and Bioinformatics support will be provided to the projects for the lifetime of the award. The NGS core will be led by experience leaders in administration and technical expertise to ensure that the core will be successful. Dr. Lieberman, is an expert in NGS and is familiar with all aspects of NGS technologies. Dr. Robertson has led many large complex programs, and is familiar with management and coordination of the technical expertise needed for success. Thus, the leadership is familiar with different NGS methodologies and bioinformatics analyses as applied to oncogenic herpesviruses and the human genome. Core C leaders have both provide unique expertise that complement each other. The NGS Core C will facilitate the ability of all members of the Program to standardize methods for sample preparation and for post-sequence bioinformatics analyses. The work will be performed at the Perelman School of Medicine in space adjacent to the Robertson lab, and in conjunction with the Penn Genomics NGS Core, and Bioinformatics core supported in part by the Abramson Cancer Center.
摘要 核心C:下一代测序核心(NGSC) 下一代测序核心(NGSC)将负责所有下一代测序活动 这四个项目。所有测序活动将在Core C.RNA-Seq、ChIP-Seq、ATAC-Seq、 核心C将负责1)执行NGS分析;2)为Illumina下一代生成文库 测序,3)将序列数据映射到EBV、KSHV、MPyV和人类基因组,以及4)提供所有 对整个项目进行后续生物信息学和生物统计分析。这些目标将在#年实现。 与宾夕法尼亚大学基因组学、下一代测序和生物信息学核心合作,提供Illumina 将下一代测序作为核心服务。最终数据管理和分析将可供访问 通过为项目调查员提供的受密码保护的共享网络浏览器发送到每个项目调查员。 精通下一代测序(NGS)、染色质免疫沉淀和生物信息学的方方面面 在奖项的有效期内,将向项目提供支持。NGS核心将由经验引领 行政领导和技术专长,以确保核心将是成功的。利伯曼博士,是 NGS专家,熟悉NGS技术的方方面面。罗伯逊博士领导了许多大型 复杂的计划,并熟悉管理和协调所需的技术专业知识 成功。因此,领导层熟悉不同的NGS方法和生物信息学分析,如 应用于致癌疱疹病毒和人类基因组。核心C领导者都提供了独特的 专业知识相辅相成。NGS核心C将促进计划所有成员的能力 标准化样品制备和序列后生物信息学分析的方法。这项工作将 在毗邻罗伯逊实验室的佩雷尔曼医学院进行,并与 宾夕法尼亚大学基因组学NGS核心,以及部分由艾布拉姆森癌症支持的生物信息学核心 中心。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ERLE S. ROBERTSON其他文献

ERLE S. ROBERTSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ERLE S. ROBERTSON', 18)}}的其他基金

Botswana-UPenn: Research Consortium of HPV-Related Cervical Cancer in HIV Patient
博茨瓦纳-宾夕法尼亚大学:HIV 患者 HPV 相关宫颈癌研究联盟
  • 批准号:
    10834480
  • 财政年份:
    2023
  • 资助金额:
    $ 45.67万
  • 项目类别:
Project 1: KSHV reprograms replication and metabolic activities in hypoxia
项目 1:KSHV 在缺氧条件下重新编程复制和代谢活动
  • 批准号:
    10714173
  • 财政年份:
    2023
  • 资助金额:
    $ 45.67万
  • 项目类别:
Transcription and Replication of Oncogenic Viruses in Hypoxia
缺氧条件下致癌病毒的转录和复制
  • 批准号:
    10714172
  • 财政年份:
    2023
  • 资助金额:
    $ 45.67万
  • 项目类别:
Virus, Vector and Cell Culture Core
病毒、载体和细胞培养核心
  • 批准号:
    10714178
  • 财政年份:
    2023
  • 资助金额:
    $ 45.67万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10714177
  • 财政年份:
    2023
  • 资助金额:
    $ 45.67万
  • 项目类别:
Project 2: KSHV induces tumorigenesis by harnessing differentiation in hypoxia
项目2:KSHV利用缺氧条件下的分化诱导肿瘤发生
  • 批准号:
    10714174
  • 财政年份:
    2023
  • 资助金额:
    $ 45.67万
  • 项目类别:
Tumor suppressor reprogramming by EBV through post-translational modification
EBV 通过翻译后修饰重编程肿瘤抑制因子
  • 批准号:
    10402055
  • 财政年份:
    2022
  • 资助金额:
    $ 45.67万
  • 项目类别:
Tumor suppressor reprogramming by EBV through post-translational modification
EBV 通过翻译后修饰重编程肿瘤抑制因子
  • 批准号:
    10684650
  • 财政年份:
    2022
  • 资助金额:
    $ 45.67万
  • 项目类别:
Epigenetic Regulation of KSHV Genome Replication
KSHV 基因组复制的表观遗传调控
  • 批准号:
    10457380
  • 财政年份:
    2019
  • 资助金额:
    $ 45.67万
  • 项目类别:
Epigenetic Regulation of KSHV Genome Replication
KSHV 基因组复制的表观遗传调控
  • 批准号:
    9978759
  • 财政年份:
    2019
  • 资助金额:
    $ 45.67万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 45.67万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 45.67万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.67万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.67万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 45.67万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.67万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 45.67万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 45.67万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 45.67万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.67万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了